• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

    8/12/25 2:48:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $SRXH alert in real time by email

    TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court").

    In connection with the Initial Order, the Court granted, among other relief:

    • a stay of proceedings in favor of SRx Canada
    • the appointment of Grant Thornton Limited as the monitor of SRx Canada (in such capacity, the "Monitor")
    • debtor-in-possession financing ("DIP Financing")
    • a sale process ("Sale Process")



    SRx Canada has secured DIP Financing (which includes insider participation). The Dip Financing consists of a credit facility of up to a maximum of $1,750,000 which is expected to be used to financing SRx Canada's working capital needs, including for continued operations and to implement the restructuring contemplated by the CCAA Proceedings. The CCAA Proceedings and DIP Financing will provide SRx Canada with the time and stability required to complete the Sale Process and identify transaction(s) which may include the sale of all or substantially all of the business or assets of SRx Canada. The Company intends to carry on the critical business of SRx Canada throughout the pendency of the CCAA Proceedings.

    Pursuant to the Initial Order, the Monitor is maintaining a case website at the following URL: https://www.doanegrantthornton.ca/Srx. All materials filed and orders granted in the CCAA Proceedings will be uploaded to the case website.

    Neither the Company nor the Company's United States subsidiary, Halo, Purely For Pets, Inc., a Delaware corporation, has made any filing under any bankruptcy code or statutory reorganization scheme either in the United States or in Canada.

    About SRx Health Solutions, Inc.

    SRx Health Solutions Inc. is an integrated Canadian healthcare services provider that operates within the specialty healthcare industry. The SRx network extends across all ten Canadian provinces, making it one of the most accessible providers of comprehensive, integrated, and customized specialty healthcare services in the country. SRx combines years of industry knowledge, technology, and patient-centric focus to create strategies and solutions that consistently exceed client expectations and drive critical patient care initiatives aimed to improve the wellness of Canadians. For more information on SRx Health Solutions Inc., please visit www.srxhealth.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company's risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

    Company Contact:

    SRx Health Solutions, Inc.

    Kent Cunningham, Chief Executive Officer

    Investor Contact:

    KCSA Strategic Communications

    Valter Pinto, Managing Director

    T: 212-896-1254

    Valter@KCSA.com



    Primary Logo

    Get the next $SRXH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRXH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRXH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Cunningham Kent Douglas

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 11:04:57 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 3 filed by new insider Cunningham Kent Douglas

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 11:01:45 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 4 filed by Conway Simon Alexander Malcolm

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    4/3/26 8:29:22 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    SEC Filings

    View All

    SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - SRX Global Inc. (0001471727) (Filer)

    7/21/26 4:07:22 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 424B3 filed by SRX Health Solutions Inc.

    424B3 - SRX Global Inc. (0001471727) (Filer)

    7/16/26 4:38:31 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form 424B3 filed by SRX Health Solutions Inc.

    424B3 - SRX Global Inc. (0001471727) (Filer)

    7/16/26 4:35:21 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SRX Global Regains Full Compliance with NYSE American Listing Standards

    NORTH PALM BEACH, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that it has received a written notification from NYSE Regulation confirming that the Company is back in compliance with all NYSE American LLC continued listing standards set forth in Part 10 of the NYSE American Company Guide. In a letter dated July 15, 2026, NYSE Regulation informed the Company that it has resolved the continued listing deficiency with respect to Section 1003(a)(i) and (ii) of the Company Guide, which had been referenced in the Exchange

    7/16/26 9:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026

    EMJX Shifted from "Stress" to "Mixed" for Bitcoin Company Files Updated Investor Presentation Outlining Performance and Strategy Management to Host Fireside Chat Today at 10:30am ET NORTH PALM BEACH, Fla., July 14, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today reported paper-traded EMJX returns of 26% from February 11, 2026 to July 10, 2026. The EMJX model reads market regime across three states — Bull, Mixed, and Stress — updating every trading day with a forward read on where crypto is heading over roughly the next 30 days. That signal

    7/14/26 9:20:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders

    NORTH PALM BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that Chief Executive Officer, Kent Cunningham, and President of EMJX and Head of Asset Management, Eric Jackson, will participate in a virtual Fireside Chat on Tuesday, July 14, 2026, to discuss recent developments, the completed EMJX acquisition, and vision for the future. SRX Global Fireside Chat Details Date: Tuesday, July 14, 2026Time: 10:30 a.m. ETModerator: Valter Pinto, Managing Director, KCSA Strategic CommunicationsPanelists: Kent Cunningh

    7/10/26 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Leadership Updates

    Live Leadership Updates

    View All

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee

    TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

    10/1/25 8:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

    TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

    8/12/25 2:48:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Financials

    Live finance-specific insights

    View All

    SRX Global Declares One-Time Cash Dividend

    NORTH PALM BEACH, Fla., July 08, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating returns across high-conviction operating companies and assets, today announced that the Board of Directors has approved a one-time cash dividend of $0.05 per share (approximately $1 million in the aggregate) on common stock outstanding to shareholders of record at the close of business on July 22, 2026 (the "Record Date"). The dividend will be paid on or about August 3, 2026 to shareholders of record on Record Date. "This special dividend reflects the strength of our investment strategy and our commitment to returning value direct

    7/8/26 9:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Closes EMJX Acquisition and Launches AI-Driven Platform Strategy Under New Name and Brand, SRX Global, Focused on Investments in High-Conviction Operating Companies and Assets

    Company announces name change to SRX Global in conjunction with transaction closingCompany's stock to remain trading on the NYSE American ("NYSE") under ticker symbol "SRXH" NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. ("EMJX") and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc

    6/18/26 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Acquires 4.99% of Smartkem, Inc. (NASDAQ: SMTK)

    NORTH PALM BEACH, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring 4.99% of Smartkem, Inc. (NASDAQ:SMTK), a leader in advanced materials, through a shelf take down. In conjunction with the 4.99% of equity, the Company has also purchased convertible preferred securities through a non-brokered private placement. Additional Information and Where to Find It In connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on F

    6/8/26 12:07:43 PM ET
    $SMTK
    $SRXH
    Semiconductors
    Technology
    Beverages (Production/Distribution)
    Consumer Staples